This tool allows the prediction of tumor control for early-stage lung cancer for different fractionation sizes and schedules. It is based on work by Jeong et al which showed that a mechanistic mathematical model can quantitatively predict the tremendous differences in response seen in early-stage lung cancer across the range of clinical dose and fractionation schemes. The model can be used to predict which fractionation schemes over- or undertreat lung tumors.
This modeling tool is meant to provide scientific insight and is not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem. We make no warranties, nor express or implied representations whatsoever, regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced in this prediction tool.